3 hours Legend Biotech (NASDAQ:LEGN) Now Covered by Redburn Atlantic MarketBeat
Redburn Atlantic initiated coverage on Legend Biotech in a report on Tuesday. They issued a “buy” rating and a $86.00 price target for the company.
Redburn Atlantic initiated coverage on Legend Biotech in a report on Tuesday. They issued a “buy” rating and a $86.00 price target for the company.